Background: Bioprosthetic heart valve has limited durability and lower long-term performance especially in rheumatic heart disease (RHD) patients that are often subject to multiple redo operations. Minimally invasive procedures, such as transcatheter valve-in-valve (ViV) implantation, may offer an attractive alternative, although data is lacking. The aim of this study was to evaluate the baseline characteristics and clinical outcomes in rheumatic vs. non-rheumatic patients undergoing ViV procedures for severe bioprosthetic valve dysfunction.Methods: Single center, prospective study, including consecutive patients undergoing transcatheter ViV implantation in aortic, mitral and tricuspid position, from May 2015 to September 2020. RHD was defi...
Background - Transcatheter valve implantation inside failed bioprosthetic surgical valves (valve-in-...
AIMS The aim of this study was to evaluate transcatheter aortic valve-in-valve (ViV) implantation...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
ObjectivesWe sought to analyze outcomes of patients with degenerated surgically implanted bioprosthe...
International audienceIntroduction Despite limited to short and midterm outcomes, valve-in-valve (Vi...
Objective This study aimed to assess short-term outcomes of patients with failed aortic valve biopro...
AbstractBioprosthetic valve use has increased significantly. Considering their limited durability, t...
ABSTRACTBackgroundRecent studies have demonstrated the efficacy of the transcatheter valve-in-valve ...
While redo surgical aortic valve replacement has traditionally been the gold standard for the treatm...
Introduction: Transcatheter aortic valve implantation (TAVI) has become an alternative to open surge...
Objective: To compare early and midterm outcomes of transcatheter valve-in-valve implantation (ViV-T...
International audienceValve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) emerged ha...
In recent years the trend towards surgical bioprosthetic valve implantation, especially among young ...
ObjectivesMitral valve replacement with bioprosthetic valves is becoming more common. The incidence ...
Background - Transcatheter valve implantation inside failed bioprosthetic surgical valves (valve-in-...
AIMS The aim of this study was to evaluate transcatheter aortic valve-in-valve (ViV) implantation...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
ObjectivesWe sought to analyze outcomes of patients with degenerated surgically implanted bioprosthe...
International audienceIntroduction Despite limited to short and midterm outcomes, valve-in-valve (Vi...
Objective This study aimed to assess short-term outcomes of patients with failed aortic valve biopro...
AbstractBioprosthetic valve use has increased significantly. Considering their limited durability, t...
ABSTRACTBackgroundRecent studies have demonstrated the efficacy of the transcatheter valve-in-valve ...
While redo surgical aortic valve replacement has traditionally been the gold standard for the treatm...
Introduction: Transcatheter aortic valve implantation (TAVI) has become an alternative to open surge...
Objective: To compare early and midterm outcomes of transcatheter valve-in-valve implantation (ViV-T...
International audienceValve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) emerged ha...
In recent years the trend towards surgical bioprosthetic valve implantation, especially among young ...
ObjectivesMitral valve replacement with bioprosthetic valves is becoming more common. The incidence ...
Background - Transcatheter valve implantation inside failed bioprosthetic surgical valves (valve-in-...
AIMS The aim of this study was to evaluate transcatheter aortic valve-in-valve (ViV) implantation...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...